Following the conclusion of the 18th Pujiang Innovation Forum, the official organizing committee announced the list of winners for the 2025 InnoMatch Technology Transfer Convention Awards. Optoseeker Biotech was successfully honored with the "Innovation Vitality Rising Star Award" for its groundbreaking technological advancements, industrial transformation potential, and application value in the field of high-end life science instrumentation.
The Pujiang Innovation Forum, jointly hosted by the Ministry of Science and Technology of China and the Shanghai Municipal People's Government, has accumulated 18 years of deep experience, becoming a vital national platform for technological innovation practice and a core window for international scientific and technological cooperation. The Forum upholds stringent selection criteria, requiring applicants to submit essential materials, including a comprehensive business plan and proof of independent intellectual property rights. After multi-level and multi-dimensional strict review by the organizers and co-organizers, Optoseeker Biotech stood out from numerous high-quality global projects. The company successfully passed the comprehensive assessment, earning a spot among the Forum's top-tier projects, demonstrating its excellent technical strength, professional team configuration, and outstanding innovative value.
Optoseeker Biotech Booth in the Innovation Enterprise Zone
This award is a strong affirmation of Optoseeker Biotech's commitment to deep-rooted technological research and development and its philosophy of "making scientific and technological achievements universally beneficial." At the "Technology Transfer Convention" product launch and exhibition area, Optoseeker Biotech showcased its independently developed core technologies, including optofluidics, AI algorithms, and optoelectronic tweezers, through key products such as the OptoBot® 1000 Series High-Throughput Single-Cell Optofluidic Sorter (a sneak preview), the OptoBot® 500 Opto-Electro-Microfluidic System, and the OptoNeuroBot® Structured Light Projector.Notably, the OptoBot® 1000 Series creates a full-process, independently controllable platform encompassing "screening – sequencing – data analysis." This system directly addresses key pain points in pharmaceutical R&D, significantly shortening the antibody screening cycle and reducing the development cost of gene therapies. Its prominent technological innovativeness and remarkable industrial application value were the core factors supporting the acquisition of the Rising Star Award.
As one of the few domestic enterprises focused on the independent R&D of high-end single-cell sorting instruments, Optoseeker Biotech consistently relies on technological breakthrough as its core driver. The "Innovation Vitality Rising Star Award" is more than just an honor; it is an industry acknowledgment of Optoseeker Biotech’s past achievements and an expectation for its future development. Looking ahead, we will use this as a new starting point to accelerate the industrialization of high-end life science instruments, offering more "Chinese Solutions" to the global biomedical industry, and contributing to the construction of an open, cooperative, universally beneficial, and sustainable global scientific and technological community.
